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Background: In 2016, the World Health Organization (WHO) strongly recommended the use of a high fraction of inspired
oxygen (FiO2) in adult patients undergoing general anaesthesia to reduce the risk of surgical site infection (SSI). Since
then, further trials have been published, trials included previously have come under scrutiny, and one article was
retracted. We updated the systematic review on which the recommendation was based.
Methods:We performed a systematic literature search from January 1990 to April 2018 for RCTs comparing the effect
of high (80%) vs standard (30e35%) FiO2 on the incidence of SSI. Studies retracted or under investigation were
excluded. A random effects model was used for meta-analyses; the sources of heterogeneity were explored using
meta-regression.
Results: Of 21 RCTs included, six were newly identified since the publication of the WHO guideline review; 17 could be
included in the final analyses. Overall, no evidence for a reduction of SSI after the use of high FiO2 was found [relative
risk (RR): 0.89; 95% confidence interval (CI): 0.73e1.07]. There was evidence that high FiO2 was beneficial in intubated
patients [RR: 0.80 (95% CI: 0.64e0.99)], but not in non-intubated patients [RR: 1.20 (95% CI: 0.91e1.58); test of interaction;
P¼0.048].
Conclusions: The WHO updated analyses did not show definite beneficial effect of the use of high perioperative FiO2,
overall, but there was evidence of effect of reducing the SSI risk in surgical patients under general anaesthesia with
tracheal intubation. However, the evidence for this beneficial effect has become weaker and the strength of the
recommendation needs to be reconsidered.l decision: 05 November 2018; Accepted: 5 November 2018
World Health Organization. Published by Elsevier Ltd. on Behalf of British Journal of Anaesthesia.
issions, please email: permissions@elsevier.com
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 In 2017, the WHO strongly recommended the use of a
high FiO2 in adult patients undergoing general anaes-
thesia to reduce the risk of surgical site infection (SSI).
 Since then, further studies and debate have raised
concerns about this recommendation, so the underly-
ing systematic review has now been updated.
 The updated analysis showed no significant effect of
the use of high perioperative FiO2 overall, but did show
evidence of reducing SSI risk in surgical patients under
general anaesthesia with tracheal intubation.
 The evidence for a beneficial effect of high periopera-
tive FiO2 has become weaker.
 The strength of the recommendation needs to be
reconsidered, and additional data from high-quality
trials are urgently needed.Surgical site infections (SSIs) are amongst the most common
healthcare-associated infections.1,2 They are a cause of
increased morbidity, mortality, and prolonged hospital stay,
including significant healthcare costs that are estimated to be
as high as US$ 16 billion per year in the USA alone.1e3 Together
with the increasing co-morbidity and complexity of surgical
patients and the associated procedures,4 the emergence of
antimicrobial resistance5,6 and continuous increase in the
number of surgical procedures performed,7 the prevention of
SSI remains of major importance to the safety, quality, and
affordability of healthcare.
There is evidence from both animal and human experi-
ments that oxygen levels at the surgical incision significantly
influence the risk of SSI.8e12 Low tissue oxygenation is asso-
ciated with an increased incidence of SSI, and it has been
hypothesised that increasing the tissue oxygen tension at the
surgical site by administering a higher fraction of inspired
oxygen (FiO2) could reduce SSI.
8,11,12 In 2000, a landmark RCT
allocated patients undergoing colorectal surgery to either
standard FiO2 of 30% or an increased FiO2 of 80%. The risk of
SSI was reduced by more than 50% in the intervention
group.13 Since then, further trials were done, but with het-
erogeneous results.14e16 Furthermore, concerns related to
potential adverse effects, such as atelectasis, respiratory
failure, cardiovascular complications, and mortality, have
been raised.17e21
In 2013, a systematic review concluded that high FiO2
during mechanical ventilation reduced the risk of SSI
without increasing the risk of atelectasis,22 but this
conclusion was later disputed by a Cochrane review that
included both intubated patients undergoing general
anaesthesia and those undergoing neuraxial anaesthesia.23
For the development of the WHO guidelines for SSI pre-
vention, published in November 2016, a systematic review
and meta-analyses were conducted in 2014 to investigate
the effects of the use of high (80%) FiO2 compared with
standard (30e35%) FiO2 on the incidence of SSI in patientsundergoing surgery. The WHO reviewers found that 80%
FiO2 was associated with a significant benefit in reducing SSI
without evidence of harm when compared with a standard
FiO2 of 30% or 35% in intubated patients.
24,25 Notably, they
found no benefit in studies using neuraxial anaesthesia,
where FiO2 was administered through a face mask or nasal
cannula whilst patients were awake.
Based on these findings and extensive discussions by the
guideline development group, WHO recommended that,
‘Adult patients undergoing general anaesthesia with
tracheal intubation for surgical procedures should receive an
80% fraction of inspired oxygen intraoperatively and, if
feasible, in the immediate postoperative period for 2e6 h to
reduce the risk of SSI’. In line with rigorous WHO standards,
details on the guideline development process, summaries of
the evidence, rationale for the recommendation, consider-
ations on resource use, values, and preferences, and
research gaps were made available.24 Since then, guidelines
by the US Centers for Disease Control and Prevention (CDC)
and other organisations have made similar
recommendations.26,27
However, these recommendations have sparked debate on
the benefits and harms of hyperoxia. Stakeholders raised their
concerns in editorials and journal correspondence.28e34 Some
concerns were based on evidence from animal studies or
clinical settings different from perioperative care, and were
countered by the available direct evidence. Other concerns
could be resolved through clarification of the Grading of Rec-
ommendations Assessment, Development and Evaluation
(GRADE) methodology35 and explanations detailing the WHO
guideline development process.36,37 There were also issues
that required further investigation and reanalysis of the
available evidence, including concerns regarding the exclu-
sion of recently published data,28e33 about studies using
nitrous oxide (N2O) in the control group,
28,33 and safety
issues.28e33 WHO responded to the commentaries,36 and
agreed that the emerging new evidence on effectiveness and
safety should be assessed. Finally, one of the trials included in
theWHO initial review24,25 has since been retracted because of
non-reproducible statistics.38 More retracted trials from the
same author were identified,39,40 and other (not retracted)
trials contained discrepancies that require further
investigation.41e43
We updated the systematic review and meta-analysis on
which the WHO recommendation was based. A systematic
review of adverse events after the use of high FiO2 has also
been conducted in response to concerns raised.44Methods
This systematic review was conducted to update the one
initially conducted for the WHO guidelines for SSI preven-
tion,24,25 following the WHO Handbook for Guideline Develop-
ment45 and reported according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses
statement.46
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A librarian was consulted for the development of the search
strategy. Medline (PubMed), Excerpta Medica Database
(EMBASE), Index Medicus, Cochrane Central Register of
Controlled Trials (CENTRAL), the Cumulative Index to Nursing
and Allied Health Literature, and WHO regional medical da-
tabases were systematically searched for studies published
between January 1, 1990 and April 20, 2018. The updated
search was conducted on April 20, 2018. Only studies pub-
lished from 1990 onwards were considered, as infection pre-
vention practices before 1990 differ from current practice,
including important related areas, such as preoperative anti-
biotic prophylaxis. No language restriction was applied.
Search terms included surgical wound infection, surgical
infection, postoperative wound infection, wound infection,
pre-, peri-, intraoperative, infection, oxygen, oxygen inhala-
tion therapy, oxygenation, inspired oxygen fraction, FiO2, and
related medical subject headings. The complete search strat-
egy is available in Supplementary Table S1.Study selection
The RCTs investigating the effect of perioperative adminis-
tration of increased (80%) compared with standard (30e35%)
FiO2 on the incidence of SSI in patients undergoing surgical
procedures were eligible. In an effort to capture all relevant
publications, no restrictionwas applied to outcome definitions
or length of follow-up. Two authors (J.S. and S.J.) indepen-
dently screened the titles and abstracts retrieved from the
search for potential eligibility. When the title and abstract
indicated potential eligibility, or if insufficient information
was supplied for assessment, the full-text article was ob-
tained. Any disagreements were resolved through discussion
or after consultation with a third author (B.A.).Data extraction
Two authors (J.S. and S.J.) independently reviewed each eligible
article and extracted relevant data using a predefined data
extraction form. Data collection included author, publication
date, design, scope, participants, type of surgery, procedure
duration, outcome definition, intervention, control, post-
operative oxygenation, tracheal intubation, base gas, preoper-
ative antibiotics, temperature, fluids, and resource use.Risk of bias
Two authors (J.S. and S.J.) independently assessed the risk of
bias of each of the included studies using the Cochrane
Collaboration tool for RCTs.47 Specifically, risk of attrition
bias was considered low if the analysis was according to the
intention-to-treat principle, or if attrition was balanced and
unlikely to have affected results. If attrition was unbalanced
and high relative to the incidence of SSI, risk of bias was
considered high. When attrition was insufficiently
described, risk of bias was considered unclear. Outcome
reporting bias was assessed by reviewing the study regis-
tration or protocol. If no outcomes were omitted or altered,
risk of bias was considered low. If no trial registration or
protocol was available, risk of outcome reporting bias was
considered unclear. Conflicts were resolved through dis-
cussion or after consultation with a third author (B.A.). The
possibility of publication bias was assessed using a contour-
enhanced funnel plot.48 A risk-of-bias graph and summarytable were constructed using Review Manager (version 5.3;
The Nordic Cochrane Centre, The Cochrane Collaboration,
Copenhagen, Denmark).Statistical analysis
The primary outcome, SSI, was expressed using the pooled
relative risk (RR) with the corresponding 95% confidence in-
terval (CI). A random effects model (DerSimonian and Laird)
was used to account for potential clinical and statistical het-
erogeneity.49 The c2 test for heterogeneity was computed and
the amount of heterogeneity was quantified by the I2 statistic.
The extent of heterogeneity was evaluated using the between-
study variance (t2). Potential sources of heterogeneity were
discussed by the guideline development group, and their
importance was examined in random effects meta-regression
analyses.50,51 Using sensitivity analyses, we examined the ef-
fect of including the studies retracted or under investigation
for concerns related to their validity at the time of the conduct
of this review. Statistical analyses were performed using Stata
version 15.0 (Stata Statistical Software, release 15; StataCorp,
College Station, TX, USA).GRADE assessment
The quality of the retrieved evidence was judged using GRADE
methodology (GRADEpro software; http://gradepro.org/).35Results
Study selection
The updated search retrieved 3005 potentially relevant re-
cords; one additional study was identified through other
sources. After removal of duplicates, 2446 records were
screened, and 69 full-text publications were assessed for
eligibility. Twenty-one RCTs were critically appraised,
including six studies published after the previous systematic
review. We excluded four studies by Schietroma and
colleagues38,41e43 because of the retraction of one paper, and
discrepancies and concerns pending clarification on the val-
idity of three others. A total of 17 RCTs were included.13e16,52
The selection procedure is summarised in Figure 1.Study characteristics
The study characteristics are shown in Table 1. A total of 7817
participants were included in 17 RCTs from Asia, Europe, and
North America that compared the effect of high (80%) to
standard (30e35%) perioperative FiO2 on the incidence of SSI.
Ten studies used the CDC definition of SSI. The remaining
studies used extensive clinical descriptions that overlapped
with the CDC definition. Follow-up ranged from 2 to 12 weeks.
All studies administered 80% FiO2 in the intervention group; 16
studies administered 30% FiO2 in the control group and one
study used 35% oxygen. Four studies used N2O in the gas
mixture. The other studies used nitrogen (N2) or room air. In 12
studies, patients were under general anaesthesia with
tracheal intubation and mechanical ventilation. In the
remaining five trials, patients were anaesthetised but awake
and breathing spontaneously, with the allocated gas mixture
delivered via a face mask or nasal cannula. Eleven studies
reported the administration of antibiotic prophylaxis in the
preoperative period. Amongst the remaining six, three studies
reported antibiotic prophylaxis administered after cord
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Fig 1. Flow chart of study selection.46 Numbers between brackets represent the original search dating from 2014. SSI, surgical site infection.
328 - de Jonge et al.clamping after Caesarean section; no specific information on
the timing of antibiotic prophylaxis was provided for the other
three. Seven studies described active warming to maintain
normal core temperature, whereas the remaining 10 did not
describe any method. Fluid regimens ranged from the
administration of 15 ml kg1 h1, and replacement of losses to
administration of fluids was limited to measured or calculated
deficits. Operative procedures ranged from surgery of the
gastrointestinal tract, including five studies specifically on
colorectal procedures, to Caesarean sections and trauma sur-
gery. Themean procedure duration ranged from 30min up to 4
h. Sixteen studies were limited to adult participants, and one
included participants of 13 yrs and older.63Risk of bias
The results of the risk-of-bias evaluation are given in Figure 2 and
Supplementary Figure S1. Overall, the risk of bias wasmoderate.
It was generally low in all domains, but sometimes unclear and
incidentally high. Selective reporting of outcomes led to a high
risk of bias in one study.62 In another study, risk of bias was high
because of lack of blinding.56 Several studies provided too little
information to determine the risk of bias. A funnel plot is pre-
sented in Supplementary Figure S2; no asymmetrywas detected.Meta-analyses, meta-regression, and sensitivity
analyses
Meta-analyses of all included trials showed little evidence
of a benefit of perioperative administration of high (80%)FiO2 on the prevention of SSI compared with standard
(30e35%) FiO2: RR: 0.89; 95% CI: 0.73e1.07 (Table 2). There
was evidence of heterogeneity (t2¼0.055; c2 test for het-
erogeneity P¼0.025; I2¼45.4%). The forest plot is presented
in Figure 3. The guideline development group noted that the
method of delivery of the intervention (i.e. under general
anaesthesia with tracheal intubation and mechanical
ventilation vs oxygen administration via a face mask or
nasal cannula without intubation) and the type of proced-
ure could be potential effect modifiers. Meta-regression
indicated that the method of oxygen administration modi-
fied the effect of administration of high FiO2 on the inci-
dence of SSI (test of interaction, P¼0.048; proportion
variance explained, 27%). In patients under general anaes-
thesia with tracheal intubation and mechanical ventilation,
80% FiO2 reduced the incidence of SSI [RR: 0.80 (95% CI:
0.64e0.99); t2¼0.051; c2 P¼0.043; I2¼46.7%]. In contrast, if
patients were awake and breathed spontaneously via a face
mask or nasal cannula, there was no evidence of a benefit of
the intervention [RR: 1.20 (95% CI: 0.91e1.58); t2¼0.000; c2
test for heterogeneity, P¼0.482; I2¼0.0 %]. The type of pro-
cedure did not affect the effect estimate (test of interaction,
P¼0.078). Similarly, there was no evidence that the use of
N2O2 in the gas mixture influenced the effect (test of
interaction, P¼0.945).
Sensitivity analysis (Supplementary Table S2) showed that
the effects were larger when the four studies either retracted
or under investigation were included41e43; the overall RR was
0.80 (95% CI: 0.67e0.97) and 0.72 (95% CI: 0.59e0.88) amongst
Table 1 Characteristics of the studies included in the systematic review. Procedure duration: mean, or if not specified, based on exclusion criterion. CDC: Centers for Disease Control and
Prevention; NA, not available; N2, nitrogen; N2O, nitrous oxide
Study Design, scope,
participants
Type of surgery,
procedure
duration
Outcome
definition
(CDC),
follow-up
Intervention
vs control
Postoperative
oxygenation
Tracheal
intubation
Base gas Preoperative
antibiotics
Temperature
regimen
Fluids
Greif and
colleagues
(2000)13
RCT, multicentre,
500
Colorectal surgery,
3.1 h
No, 15 days 80% vs 30% 2 h Yes N2 Yes 36C 15 ml kg1 h1
Pryor and
colleagues
(2004)14
RCT, single centre,
160
Major abdominal
surgery, 3.7 h
No, 14 days 80% vs 30% 2 h Yes NA, N2O
included
Yes NA NA
Belda and
colleagues
(2005)15
RCT, multicentre,
291
Colorectal surgery,
>1 h
Yes, 14 days 80% vs 30% 6 h Yes Air Yes Active 15 ml kg1 h1
Mayzler and
colleagues
(2005)52
RCT, single centre,
38
Colorectal surgery,
2.3 h
Yes, 30 days 80% vs 30% 2 h Yes N2, N2O Yes 35.5C 15 ml kg1 h1
Myles and
colleagues
(2007)53
RCT, multicentre,
2012
Surgery >2 h, 3.3 h Yes, 30 days 80% vs 30% No Yes N2, N2O Institutional
practice
>35.5 Anaesthesiologist’s
discretion
Gardella and
colleagues
(2008)54
RCT, single centre,
143
Caesarean section,
0.8 h
No, 14 days 80% vs 30% 2 h No Air No NA NA
Meyhoff and
colleagues
(2009)16
RCT, multicentre,
1386
Laparotomies, 2.2 h Yes, 14 days 80% vs 30% 2 h Yes NA, N2O
free
Yes NA Only to replace
deficits
Bickel and
colleagues
(2011)55
RCT, single centre,
210
Open
appendectomy,
0.5 h
No, 14 days 80% vs 30% 2 h Yes Air and N2 Yes Active NA
Scifres and
colleagues
(2011)56
RCT, single centre,
585
Caesarean section, 1
h
Yes, 4 weeks 80% vs 30% 2 h No Air Yes NA NA
Thibon and
colleagues
(2012)57
RCT, multicentre,
434
Abdominal,
gynaecological,
and breast
surgery, 1.5 h
Yes, 30 days 80% vs 30% No Yes NA NA NA NA
Duggal and
colleagues
(2013)59
RCT, single centre,
831
Caesarean section,
NA
Yes plus
endometritis,
2 weeks
80% vs 30%
(after cord
clamping)
1 h No Air No NA NA
Williams and
colleagues
(2013)61
RCT, single centre,
160
Caesarean section,
0.9 h
Yes plus
endometritis,
30 days
80% vs 30% 2 h No Air No NA NA
Stall and
colleagues
(2013)60
RCT, single centre,
235
Open reduction and
internal fixation,
3.8 h
Yes, 12 weeks 80% vs 30% 2 h Yes NA Yes NA NA
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Fig 2. Risk-of-bias summary. Green bubbles represent low risk of
bias, yellow bubbles represent unclear risk of bias, and red
bubbles represent high risk of bias.
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330 - de Jonge et al.intubated patients only. The results from the meta-regression
analyses were similar to the main analysis. The meta-
regression analysis comparing the four excluded studies
with the 17 included studies indicated that the excluded pa-
pers would have significantly influenced the effect (test of
interaction, P¼0.01).
Quality of the evidence on the relative effect of the use
of high FiO2
The GRADE assessment was restricted to studies describing
patients undergoing general anaesthesia with tracheal intu-
bation and mechanical ventilation. All included studies were
RCTs, thus resulting in high starting quality. Overall, the
quality of evidence was assessed as moderate (Supplementary
Table S3).
Table 2 Results of meta-analyses and meta-regression analyses. SSI, surgical site infection
Studies, N SSI in the
intervention
groups, n/N
SSI in the
control
groups, n/N
Relative risk (95%
confidence interval)
Test of interaction
from meta-regression
(P-value)
Between-study
variance (t2)
Variance
explained (%)
Overall
All 17 446/3889 514/3928 0.89 (0.73e1.07) NA 0.055 NA
By delivery of oxygen: intubation (yes/no)
Yes 12 350/2978 431/2998 0.80 (0.64e0.99) 0.048 0.04 27
No 5 96/911 83/930 1.20 (0.91e1.58)
By type of procedure: colorectal (yes/no)
Yes 5 87/732 127/743 0.68 (0.49e0.96) 0.078 0.05 9
No 12 359/3157 387/3185 0.98 (0.79e1.23)
By gas mixture: N2O (yes/no)
Yes 4 104/1126 137/1175 0.92 (0.48e1.73) 0.945 0.069 0
No 13 342/2763 377/2753 0.89 (0.73e1.09)
Effectiveness of hyperoxia during surgery - 331Discussion
In this update of the previous systematic review performed in
January 201425 and used for developing the WHO guideline,24
we applied the same rigorous approach. Subgroup analysesFig 3. Forest plot analysis by delivery of the intervention. The X-axis r
individual study. The solid diamonds and horizontal lines represent p
the individual studies, respectively. The transparent diamonds repres
group, and the overall analysis.were conducted to investigate possible effect modifications.
Furthermore, we adopted a conservative approach in
excluding four trials by Schietroma and colleagues,38,41e43 as
one has been recently retracted and others are underepresents relative risk (RR); each row on the Y-axis represents an
oint estimates and corresponding 95% confidence intervals (CIs) of
ent the pooled estimate and 95% confidence interval of each sub-
332 - de Jonge et al.investigation. The meta-analysis of all 17 RCTs, including 6552
patients, showed no evidence for a benefit of the use of high
(80%) FiO2 in reducing the incidence of SSI when compared
with standard FiO2 (30e35%). However, similar to the previous
analysis, subgroup analyses and meta-regression showed an
association between the delivery of the intervention and the
effect estimate. In studies where the intervention was
administered under general anaesthesia with tracheal intu-
bation and mechanical ventilation, there was evidence of a
benefit of the use of high FiO2. In contrast, there was no evi-
dence of a benefit or heterogeneity detected when patients
were anaesthetised, but breathing their allocated gas mixture
administered via a face mask or nasal cannula. Further sub-
group analyses showed no evidence for effect modification by
surgical procedure type or by gas mixture, as suggested by
some commentaries published in response to the initial WHO
recommendation.28e33
This update of the analysis is in line with our original re-
view and earlier findings by other authors.22,23,25,65 However,
effect modification by means of oxygen administration was
not analysed in two recent reviews, despite recognition of the
potential relevance of the type of anaesthesia23,65 and an
indication of effect in patients under general anaesthesia with
tracheal intubation, as shown in an earlier review.22 None-
theless, the evidence from our updated analysis has become
weaker after the exclusion of four studies with disputed
credibility38,41e43 and the net addition of four new trials.58,62e64
The additional information did not strengthen the evidence
for effect modification found in the original review and the
evidence for a benefit in patients undergoing general anaes-
thesia with tracheal intubation that led to the strong recom-
mendation in the WHO guidelines.24,25 The meta-regression
analysis indicated that the excluded studies by Schietroma
and colleagues38,41e43 would have significantly influenced the
effect if they had been retained in the analysis. The sensitivity
analysis, including these trials, showed larger effect estimates
and, notably, a significant effect in the overall analysis and
strong effect modification according to the method of oxygen
administration. However, given the concerns about these tri-
als, inclusion was no longer justified. At present, three large
new RCTs on the effect of high perioperative FiO2 are regis-
tered at www.clincaltrials.gov. Once completed, these trials
may clarify the issue.Limitations
This review has some limitations. Although the methodol-
ogy was developed in a rigorous process consistently
applied by WHO when gathering evidence for the develop-
ment of the guidelines, the subgroup analyses described
here and identified as critical by the experts were not pre-
specified. This is a limitation carrying the risk of Type 1
error. However, the substantial difference in the interven-
tion effect and the clear biological difference in the inter-
vention, and statistical support for effect measure
modification, led the guideline development group to
believe that reporting of this effect was warranted and
should inform the patient population concerned by the
recommendation. Other limitations of our analysis are
related to pooling studies that span nearly 20 yrs and cover
an intervention in a complex and rapidly evolving field,
inevitably introducing heterogeneity in the analysis.
The WHO has taken the concerns expressed by external
experts on the validity of the evidence base of itsrecommendation on the use of high FiO2 very seriously, and
has updated the systematic review and conducted further
analyses, excluding trials of uncertain validity. Furthermore,
in order to respond to concerns about the potential harm of
administering high FiO2, the WHO commissioned a separate
independent systematic review on adverse events associated
with this intervention in patients undergoing surgical
procedures.44
In conclusion, whilst no effect of the use of high FiO2 in the
perioperative phase was found in the overall analysis, this
intervention delivered through intubation and mechanical
ventilation may reduce the risk of SSI. However, the evidence
for a beneficial effect has become weaker and the strength of
the recommendation needs to be reconsidered. The WHO
guideline development group will reconvene to discuss the
implications of these findings. Additional data from high-
quality trials are urgently needed, as well as a timely revi-
sion of the guidelines to account for future relevant newly
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